So they go on to say along the lines of expecting revenue on Lymphoseek sales of $5 - $6 million...Not sure if that means they are expecting $5 - $6 million or $2.5 - $3 million. It suggests the 5 to 6 coming into NAVB, but that would be 10 to 12 in sales by Cardinal. My guess is the 2.5 to 3 million to NAVB... Companies are all the same...spin the words confuse everyone. They all go to the same school for corporate communications. All have the same lingo..."executing to plan" "we are pleased with the progress" "excited about the future" "it was a pivotal year/quarter" Okay, next quarter we are going to play "corporate lingo bingo"!
LS sales of $10-12 million in 2014 will be amazing considering that, "Revenues from sales of Lymphoseek for the fourth quarter of 2013 were $343,000." Meaning Q4 sales of LS were $686,000. Those 2014 numbers are pretty lofty guidance, now they have to produce.